Evidence-Based Decision for Pharmacological Management of Alcoholic Liver Disease and Alcohol Dependence

Addolorato G, Leggio L, Ferrulli A, Cardone S, Vonghia L, Mirijello A, Abenavoli L, D’Angelo C, Caputo F, Zambon A, Haber PS, Gasbarrini G (2007) Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 370:1915–1922PubMedCrossRef
Akriviadis E, Botla R, Briggs W et al (2000) Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo controlled trial. Gastroenterology 119:1637–1648PubMedCrossRef
Alexander JF, Lichner MW, Galambos JT (1971) Natural history of alcoholic hepatitis. The long-term prognosis. Am J Gastroenterol 56:515–525PubMed
Anton RF, O’Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A, COMBINE Study Research Group (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295:2003–2017PubMedCrossRef
Becker Deis U, Soresen TI et al (1996) Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 23:1025–1029CrossRef
Bellamy CO, DiMartini AM, Ruppert K et al (2001) Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation 72:619–626PubMedCrossRef
Boetticher NC, Peine CJ, Kwo P et al (2008) A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology 135:1953–1960PubMedCrossRef
Cabrè E, Gonzalez Huix F, Abad-Lacruz A et al (1990) Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology 98:715–720PubMed
Cabrè E, Rodriguez Iglesias P, Caballeria J et al (2000) On behalf of the spanish group for the Study of Alcoholic Hepatitis. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology 32:36–42PubMedCrossRef
Caputo F, Addolorato G, Stoppo M, Francini S, Vignoli T, Lorenzini F, Del Re A, Comaschi C, Andreone P, Trevisani F, Bernardi M (2007) Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomised comparative study. Eur Neuropsychopharmacol 17:781–789PubMedCrossRef
Cohen SM, Ahn J (2009) Diagnosis and Management of Alcoholic Hepatitis. Aliment Pharmacol Ther 30(1):3–13PubMedCrossRef
De BK, Gangopadhyay S, Dutta D et al (2009) Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial. World J Gastroenterol 15:1613–1619PubMedCrossRef
Dew MA, DiMartini AF, Steel J, De Vito Dabbs A, Myaskovsky L, Unruh M, Greenhouse J (2008) Meta-analysis of risk for relapse to substance use after trans plantation of the liver or other solid organs. Liver Transpl 14(2):159–172PubMedCrossRef
DiMartini A, Day N, Dew MA et al (2006) Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl 12:813–820PubMedCrossRef
Forrest EH, Evans CD, Stewart S et al (2005) Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut 54:1174–1179PubMedCrossRef
Foster PF, Fabrega F, Karademir S et al (1997) Prediction of abstinence from ethanol in alcoholic recipients following liver transplantation. Hepatology 25:1469–1477PubMedCrossRef
Only gold members can continue reading. Log In or Register to continue

Nov 16, 2015 | Posted by in General Dentistry | Comments Off on Evidence-Based Decision for Pharmacological Management of Alcoholic Liver Disease and Alcohol Dependence
Premium Wordpress Themes by UFO Themes